That’s why this year, I’m doubling down on my encouragement to embrace failure. Nothing will better prepare you for the highs and lows of owning a business or give you better insights you can apply ...

A record-breaking 1,200 startups with a billion dollar valuation have turned into dead weight. I have some insight into why that is.

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...

Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.